Bisphosphonate use in conditions other than osteoporosis.
Bisphosphonates are the gold standard of treatment of postmenopausal osteoporosis, male osteoporosis, and steroid-induced osteoporosis. They have potential use in multiple musculoskeletal conditions other than osteoporosis and have also been shown to treat Paget's disease of the bone and osteogenesis imperfecta. Bisphophonates may have potential use in periprosthetic bone loss, osteonecrosis of the hip, fibrous dysplasia, and calcinosis in juvenile dermatomyositis.
Silverman
Stuart L
SL
Cedars-Sinai/University of California at Los Angeles, Beverly Hills, California, USA. stuarts@omcresearch.org
D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced; D008297:Male; D010001:Osteitis Deformans / Q000188:drug therapy*; D010013:Osteogenesis Imperfecta / Q000188:drug therapy*; D010020:Osteonecrosis / Q000139:chemically induced; D010024:Osteoporosis / Q000188:drug therapy*; D012307:Risk Factors; D016896:Treatment Outcome
D004164:Diphosphonates